212 related articles for article (PubMed ID: 36698183)
1. Low expression of the dynamic network markers FOS/JUN in pre-deteriorated epithelial cells is associated with the progression of colorectal adenoma to carcinoma.
Huang X; Han C; Zhong J; Hu J; Jin Y; Zhang Q; Luo W; Liu R; Ling F
J Transl Med; 2023 Jan; 21(1):45. PubMed ID: 36698183
[TBL] [Abstract][Full Text] [Related]
2. Analysis of potential genes and pathways associated with the colorectal normal mucosa-adenoma-carcinoma sequence.
Wu Z; Liu Z; Ge W; Shou J; You L; Pan H; Han W
Cancer Med; 2018 Jun; 7(6):2555-2566. PubMed ID: 29659199
[TBL] [Abstract][Full Text] [Related]
3. Identification of Key Genes in Colorectal Cancer Regulated by miR-34a.
Wang T; Xu H; Liu X; Chen S; Zhou Y; Zhang X
Med Sci Monit; 2017 Dec; 23():5735-5743. PubMed ID: 29197895
[TBL] [Abstract][Full Text] [Related]
4. The p53-inducible CLDN7 regulates colorectal tumorigenesis and has prognostic significance.
Hou Y; Hou L; Liang Y; Zhang Q; Hong X; Wang Y; Huang X; Zhong T; Pang W; Xu C; Zhu L; Li L; Fang J; Meng X
Neoplasia; 2020 Nov; 22(11):590-603. PubMed ID: 32992138
[TBL] [Abstract][Full Text] [Related]
5. Identification and Interaction Analysis of Molecular Markers in Colorectal Cancer by Integrated Bioinformatics Analysis.
Han B; Feng D; Yu X; Zhang Y; Liu Y; Zhou L
Med Sci Monit; 2018 Aug; 24():6059-6069. PubMed ID: 30168505
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical detection of RAS, JUN, FOS, and p53 oncoprotein expression in human colorectal adenomas and carcinomas.
Magrisso IJ; Richmond RE; Carter JH; Pross CB; Gilfillen RA; Carter HW
Lab Invest; 1993 Dec; 69(6):674-81. PubMed ID: 8264230
[TBL] [Abstract][Full Text] [Related]
7. RNA sequencing reveals the expression profiles of circRNA and indicates that circDDX17 acts as a tumor suppressor in colorectal cancer.
Li XN; Wang ZJ; Ye CX; Zhao BC; Li ZL; Yang Y
J Exp Clin Cancer Res; 2018 Dec; 37(1):325. PubMed ID: 30591054
[TBL] [Abstract][Full Text] [Related]
8. Network-Based Genetic Profiling Reveals Cellular Pathway Differences Between Follicular Thyroid Carcinoma and Follicular Thyroid Adenoma.
Hossain MA; Asa TA; Rahman MM; Uddin S; Moustafa AA; Quinn JMW; Moni MA
Int J Environ Res Public Health; 2020 Feb; 17(4):. PubMed ID: 32093341
[TBL] [Abstract][Full Text] [Related]
9. Screening key genes and signaling pathways in colorectal cancer by integrated bioinformatics analysis.
Yu C; Chen F; Jiang J; Zhang H; Zhou M
Mol Med Rep; 2019 Aug; 20(2):1259-1269. PubMed ID: 31173250
[TBL] [Abstract][Full Text] [Related]
10. Employing bioinformatics analysis to identify hub genes and microRNAs involved in colorectal cancer.
Ebadfardzadeh J; Kazemi M; Aghazadeh A; Rezaei M; Shirvaliloo M; Sheervalilou R
Med Oncol; 2021 Aug; 38(9):114. PubMed ID: 34390411
[TBL] [Abstract][Full Text] [Related]
11. The identification of a common different gene expression signature in patients with colorectal cancer.
Zhao ZW; Fan XX; Yang LL; Song JJ; Fang SJ; Tu JF; Chen MJ; Zheng LY; Wu FZ; Zhang DK; Ying XH; Ji JS
Math Biosci Eng; 2019 Apr; 16(4):2942-2958. PubMed ID: 31137244
[TBL] [Abstract][Full Text] [Related]
12. Identification of potential biomarkers with colorectal cancer based on bioinformatics analysis and machine learning.
Hammad A; Elshaer M; Tang X
Math Biosci Eng; 2021 Oct; 18(6):8997-9015. PubMed ID: 34814332
[TBL] [Abstract][Full Text] [Related]
13. CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer.
Yue Y; Zhang Q; Sun Z
Front Immunol; 2021; 12():758040. PubMed ID: 35140706
[TBL] [Abstract][Full Text] [Related]
14. Identification of key pathways and genes in colorectal cancer using bioinformatics analysis.
Liang B; Li C; Zhao J
Med Oncol; 2016 Oct; 33(10):111. PubMed ID: 27581154
[TBL] [Abstract][Full Text] [Related]
15. Identification of potential hub genes via bioinformatics analysis combined with experimental verification in colorectal cancer.
Zhou H; Yang Z; Yue J; Chen Y; Chen T; Mu T; Liu H; Bi X
Mol Carcinog; 2020 Apr; 59(4):425-438. PubMed ID: 32064687
[TBL] [Abstract][Full Text] [Related]
16. CKIα ablation highlights a critical role for p53 in invasiveness control.
Elyada E; Pribluda A; Goldstein RE; Morgenstern Y; Brachya G; Cojocaru G; Snir-Alkalay I; Burstain I; Haffner-Krausz R; Jung S; Wiener Z; Alitalo K; Oren M; Pikarsky E; Ben-Neriah Y
Nature; 2011 Feb; 470(7334):409-13. PubMed ID: 21331045
[TBL] [Abstract][Full Text] [Related]
17. Integration of gene expression data identifies key genes and pathways in colorectal cancer.
Hozhabri H; Lashkari A; Razavi SM; Mohammadian A
Med Oncol; 2021 Jan; 38(1):7. PubMed ID: 33411100
[TBL] [Abstract][Full Text] [Related]
18. Bioinformatics-based identification of key genes and pathways associated with colorectal cancer diagnosis, treatment, and prognosis.
Wang C; Zhang L
Medicine (Baltimore); 2022 Sep; 101(37):e30619. PubMed ID: 36123948
[TBL] [Abstract][Full Text] [Related]
19. Dynamic Network Biomarker of Pre-Exhausted CD8
Hu J; Han C; Zhong J; Liu H; Liu R; Luo W; Chen P; Ling F
Front Immunol; 2021; 12():691142. PubMed ID: 34434188
[TBL] [Abstract][Full Text] [Related]
20. Construction of an miRNA‑gene regulatory network in colorectal cancer through integrated analysis of mRNA and miRNA microarrays.
Hu J; Yue X; Liu J; Kong D
Mol Med Rep; 2018 Dec; 18(6):5109-5116. PubMed ID: 30272280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
